Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

A Positive Feedback Loop between YTHDC1 and EP300 Drives Tumorigenesis in Multiple Myeloma

Yifan Hou, Jianwei Qu, Enfan Zhang, Zhen Cai

Blood (2024) 144 (Supplement 1): 4647.

https://doi.org/10.1182/blood-2024-207016

Published: 2024

Journal Articles

E3 Ubiquitin Ligase TRIM21 Enhances Macrophage-Mediated Bortezomib Resistance By Inducing M2 Polarization in Multiple Myeloma

Wen Cao, Jing Chen, Enfan Zhang, Zhen Cai

Blood (2024) 144 (Supplement 1): 6829.

https://doi.org/10.1182/blood-2024-209627

Published: 2024

Journal Articles

Myeloma-Associated Macrophages Protect Tumor Cells By Reprogramming of Lipid Metabolism through SREBP1

Xing Guo, Zhenfeng Dai, Enfan Zhang, Zhen Cai

Blood (2024) 144 (Supplement 1): 6858.

https://doi.org/10.1182/blood-2024-210568

Published: 2024

Journal Articles

The Ratio of Urea Nitrogen to Albumin Is a Better Predictor of OS in MM Patients Than That of Urea Nitrogen Alone

Mengmeng Dong, Jiaqi Shao, Enfan Zhang, Haoguang Chen, Zhen Cai, Tao Cheng

Blood (2023) 142 (Supplement 1): 6688.

https://doi.org/10.1182/blood-2023-184847

Published: 2023

Journal Articles

Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma:Pathological Phenotype and Genetic Mutation Analysis of 12 Patients

Linlin Huang, Hanjin Yang, Yang Yang, Fang Yu, Yi Zhao, Xiujin Ye, Weiyan Zheng, Jie Sun, Enfan Zhang, Zhen Cai, Jingsong He

Blood (2023) 142 (Supplement 1): 4448.

https://doi.org/10.1182/blood-2023-186056

Published: 2023

Journal Articles

Increase of Dnts Correlated with Clinic Outcome after Allogeneic DNT Cells Infusion in r/r AML Patients

Huiyao Gu, Donghua He, Xiaofeng Han, Yi Li, Li Yang, Enfan Zhang, Haicun Xie, Yu Cheng, Fuqiang Wu, Guangrong Song, Daqing Liu, Liming Yang, Jingsong He, Zhen Cai

Blood (2023) 142 (Supplement 1): 6867.

https://doi.org/10.1182/blood-2023-186221

Published: 2023

Journal Articles

Gain or Amplification of Chromosome 1q Mediate Multiple Myeloma Resistant to Xpo-1 Inhibitor Selinexor Via Transcription Factor ETV3

Huiyao Gu, Yi Zhong, Enfan Zhang, Liqin Cao, Zhen Cai, Jingsong He

Blood (2023) 142 (Supplement 1): 6579.

https://doi.org/10.1182/blood-2023-184720

Published: 2023

Journal Articles

E3 Ubiquitin Ligase TRIM21 Enhances Macrophage-Mediated Bortezomib Resistance By Inducing M2 Polarization in Multiple Myeloma

Wen Cao, Jing Chen, Enfan Zhang, Zhen Cai

Blood (2023) 142 (Supplement 1): 5730.

https://doi.org/10.1182/blood-2023-174448

Published: 2023

Journal Articles

FGFR1OP2 Promotes Proliferation and Survival of Myeloma Cells and Is a Potential Therapeutic Target

Yang Yang, Enfan Zhang, He Huang, Zhen Cai

Blood (2022) 140 (Supplement 1): 12464–12465.

https://doi.org/10.1182/blood-2022-169373

Published: 2022

Journal Articles

EGFR and HDAC Dual-Target Inhibitor CUDC-101 Enhances the Anti-Myeloma Effects of Bortezomib By Regulating the G2/M Cell Cycle Arrest

Wen Cao, Enfan Zhang, He Huang, Jing Chen, Yang Liu, Zhen Cai

Blood (2022) 140 (Supplement 1): 12438.

https://doi.org/10.1182/blood-2022-157171

Published: 2022

Journal Articles

The Efficacy of Residual Plerixafor of Second-Day Stem Cell Mobilization in Multiple Myeloma Patients

Donghua He, Chunting Zhu, Xing Guo, Xin Huang, Xiaoyan Han, GaoFeng Zheng, Yi Zhao, Yang Yang, Wenjun Wu, Jimei Ge, Enfan Zhang, He Huang, Jingsong He, Zhen Cai

Blood (2022) 140 (Supplement 1): 12813–12814.

https://doi.org/10.1182/blood-2022-166394

Published: 2022

Journal Articles

Cytomegalovirus and Epstein-Barr Virus Infection during Daratumumab Treatment in Patients with Multiple Myeloma

Shuchan Li, Xiaoyan Han, Enfan Zhang, He Huang, Zhen Cai

Blood (2022) 140 (Supplement 1): 12490–12491.

https://doi.org/10.1182/blood-2022-164522

Published: 2022

Journal Articles

Efficacy and Safety of Chidamide Combined with Thalidomide, Cyclophosphamide, and Dexamethasone (TC2D) As a Novel Oral Quadruplet Regimen for the Treatment of Relapsed/Refractory Multiple Myeloma: Initial Results of a Phase IIa, Multicenter Clinical Trial

Yi Li, Jingsong He, Xiaoyan Han, Gaofeng Zheng, Enfan Zhang, Qingxiao Chen, Donghua He, Yi Zhao, Jiaping Fu, Lihong Shou, Wenhua Jiang, Wei Jiang, Shenxian Qian, Huixian Hu, He Huang, Zhen Cai

Blood (2021) 138 (Supplement 1): 4761.

https://doi.org/10.1182/blood-2021-149188

Published: 2021

Journal Articles

ALKBH5 Functions As an Oncogene in Multiple Myeloma

Jianwei Qu, Yifan Hou, Qingxiao Chen, Jing Chen, YI LI, Enfan Zhang, Huiyao Gu, Ruyi Xu, Yang Liu, Jingsong He, He Huang, Zhen Cai

Blood (2021) 138 (Supplement 1): 3326.

https://doi.org/10.1182/blood-2021-149622

Published: 2021

Journal Articles

Myeloma Induce Fapα+ Macrophage to Remodel Immune Microenvironment Which Lead to Anti-PD-1 Dilemma

Huiyao Gu, Jingsong He, MD, Enfan Zhang, Zhen Cai, MD PhD

Blood (2020) 136 (Supplement 1): 22.

https://doi.org/10.1182/blood-2020-139535

Published: 2020

Journal Articles

Macrophages Promote DNA Repair of Double Strand Break in Multiple Myeloma Cells By Non-Homologous End Joining(NHEJ), Nevertheless Decrease Its Accuracy

Mengmeng Dong, Enfan Zhang, Haimeng Yan, MD, Ruyi Xu, He Huang, Anyong Xie, Zhen Cai, MD PhD

Blood (2019) 134 (Supplement_1): 3087.

https://doi.org/10.1182/blood-2019-126753

Published: 2019

Journal Articles

Interleukin-32 Induce Production of IL-6 in Multiple Myeloma Bone Marrow Stromal Cells

Xuanru Lin, M.MD, Xing Guo, M.MD, Jing Chen, M.MD, Qingxiao Chen, M.MD, Enfan Zhang, M.MD, Yi Li, PhD, Li Yang, PhD, Jingsong He, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 3253.

https://doi.org/10.1182/blood.V128.22.3253.3253

Published: 2016

Journal Articles

TET2 Downregulation Promotes AML Cell Proliferation Via Pim-1 Expression

Qingxiao Chen, M.MD, Jingsong He, Xing Guo, M.MD, Jing Chen, M.MD, Xuanru Lin, M.MD, Xi Huang, M.MD, Haimeng Yan, Li Yang, PhD, Yi Li, PhD, Enfan Zhang, M.MD, Yang Yang, PhD, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 5085.

https://doi.org/10.1182/blood.V128.22.5085.5085

Published: 2016

Journal Articles

AMPK Expressed By Multiple Myeloma Cells Inhibited Metformin-Induced Myeloma Cells Proliferation

Fuming Zi, PhD, Jingsong He, Enfan Zhang, M.MD, Yang Yang, PhD, He Huang, MD PhD, Qing Yi, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 5703.

https://doi.org/10.1182/blood.V128.22.5703.5703

Published: 2016

Journal Articles

Interactions Between BAFF and BAFF Receptors Are Involved in Macrophage-Induced Bortezomib Resistance in Myeloma

Jing Chen, M.MD, Donghua He, PhD, Xing Guo, M.MD, Qingxiao Chen, M.MD, Xuanru Lin, M.MD, Jingsong He, Xi Huang, M.MD, Haimeng Yan, Yi Li, PhD, Li Yang, PhD, Yang Yang, PhD, Enfan Zhang, M.MD, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 4429.

https://doi.org/10.1182/blood.V128.22.4429.4429

Published: 2016

NARROW

A Positive Feedback Loop between YTHDC1 and EP300 Drives Tumorigenesis in Multiple Myeloma

E3 Ubiquitin Ligase TRIM21 Enhances Macrophage-Mediated Bortezomib Resistance By Inducing M2 Polarization in Multiple Myeloma

Myeloma-Associated Macrophages Protect Tumor Cells By Reprogramming of Lipid Metabolism through SREBP1

The Ratio of Urea Nitrogen to Albumin Is a Better Predictor of OS in MM Patients Than That of Urea Nitrogen Alone

Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma:Pathological Phenotype and Genetic Mutation Analysis of 12 Patients

Increase of Dnts Correlated with Clinic Outcome after Allogeneic DNT Cells Infusion in r/r AML Patients

Gain or Amplification of Chromosome 1q Mediate Multiple Myeloma Resistant to Xpo-1 Inhibitor Selinexor Via Transcription Factor ETV3

E3 Ubiquitin Ligase TRIM21 Enhances Macrophage-Mediated Bortezomib Resistance By Inducing M2 Polarization in Multiple Myeloma

FGFR1OP2 Promotes Proliferation and Survival of Myeloma Cells and Is a Potential Therapeutic Target

EGFR and HDAC Dual-Target Inhibitor CUDC-101 Enhances the Anti-Myeloma Effects of Bortezomib By Regulating the G2/M Cell Cycle Arrest

The Efficacy of Residual Plerixafor of Second-Day Stem Cell Mobilization in Multiple Myeloma Patients

Cytomegalovirus and Epstein-Barr Virus Infection during Daratumumab Treatment in Patients with Multiple Myeloma

Efficacy and Safety of Chidamide Combined with Thalidomide, Cyclophosphamide, and Dexamethasone (TC2D) As a Novel Oral Quadruplet Regimen for the Treatment of Relapsed/Refractory Multiple Myeloma: Initial Results of a Phase IIa, Multicenter Clinical Trial

ALKBH5 Functions As an Oncogene in Multiple Myeloma

Myeloma Induce Fapα+ Macrophage to Remodel Immune Microenvironment Which Lead to Anti-PD-1 Dilemma

Macrophages Promote DNA Repair of Double Strand Break in Multiple Myeloma Cells By Non-Homologous End Joining(NHEJ), Nevertheless Decrease Its Accuracy

Interleukin-32 Induce Production of IL-6 in Multiple Myeloma Bone Marrow Stromal Cells

TET2 Downregulation Promotes AML Cell Proliferation Via Pim-1 Expression

AMPK Expressed By Multiple Myeloma Cells Inhibited Metformin-Induced Myeloma Cells Proliferation

Interactions Between BAFF and BAFF Receptors Are Involved in Macrophage-Induced Bortezomib Resistance in Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only